Skip to main content
. 2023 Jan 12;14:1–13. doi: 10.18632/oncotarget.28341

Figure 1. SP7219 and STRO-001 showed similar high affinity binding to human and cynomolgus monkey CD74, no binding to mouse CD74.

Figure 1

Anti-GFP antibody SP7824 was used as negative control in the cell binding experiments. (A) SP7219 and STRO-001 showed similar high affinity cell binding on CHO cells over-expressing human and cynomolgus monkey CD74. (B) SP7219 and STRO-001 showed no binding to mouse B cell line A20. The mouse CD74 expression on A20 was confirmed by a commercial anti-mouse-CD74 antibody from R&D Systems.